The impact of bleeding history, von willebrand factor and PFA-100® on the diagnosis of type 1 von willebrand disease: Results from the european study MCMDM-1VWD

British Journal of Haematology

Volumn 151, Issue 3, 2010, Pages 245-251

  Castaman, Giancarlo ^a   Tosetto, Alberto ^a   Goodeve, Anne ^b   Federici, Augusto B ^c   Lethagen, Stefan ^d   Budde, Ulrich ^e   Batlle, Javier ^f   Meyer, Dominique ^g   Mazurier, Claudine ^h   Goudemand, Jenny ⁱ   Eikenboom, Jeroen ^j   Schneppenheim, Reinhard ^k   Ingerslev, Jorgen ^l   Habart, David ^m   Hill, Frank ⁿ   Peake, Ian ^b   Rodeghiero, Francesco ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF MILAN   (Italy)

^d LUND UNIVERSITY   (Sweden)

^e Coagulation Laboratory   (Germany)

^f Hospital Teresa Herrera   (Spain)

^g INSERM   (France)

^h Laboratoire Francais du Fractionnement et des Biotechnologies   (France)

ⁱ UNIV LILLE   (France)

^j LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^k UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^l AARHUS UNIVERSITY HOSPITAL   (Denmark)

^m INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

ⁿ BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

more..

Author keywords

Bleeding score; Inherited bleeding disorders; PFA 100 closure time; Von Willebrand disease; Von Willebrand factor

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR ANTIGEN; VON WILLEBRAND FACTOR RISTOCETIN COFACTOR; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; BLEEDING SCORE; CHILD; CONTROLLED STUDY; DIAGNOSTIC VALUE; EUROPE; FEMALE; HUMAN; LABORATORY TEST; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PLATELET FUNCTION ANALYZER 100; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; VON WILLEBRAND DISEASE; BLOOD; BLOOD CLOTTING PARAMETERS; CLINICAL TRIAL; GENETIC LINKAGE; GENETICS; INFANT; MIDDLE AGED; MULTICENTER STUDY; PHENOTYPE; REFERENCE VALUE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC LINKAGE; HUMANS; INFANT; MALE; MIDDLE AGED; PHENOTYPE; PLATELET FUNCTION TESTS; REFERENCE VALUES; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 79952049046     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08333.x     Document Type: Article

References (19)

1. Breiman, L., Friedman, J., Olshen, R. & Stone, C. (1984) Classification and Regression Trees. Wadsworth, Pacific Grove.
2. Castaman, G., Federici, A.B., Rodeghiero, F. & Mannucci, P.M. (2003) Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica, 88, 94-108.
3. Cattaneo, M. (2004) Are the bleeding time and PFA-100 useful in the initial screening of patients with mucocutaneous bleedings of hereditary nature? Journal of Thrombosis and Haemostasis, 2, 809-811.
4. Cattaneo, M., Federici, A.B., Lecchi, A., Agati, B., Lombardi, R., Stabile, F. & Bucciarelli, P. (1999) Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease. Thrombosis and Haemostasis, 82, 35-39.
5. Daly, M.E., Dawood, B.B., Lester, W.A., Peake, I.R., Rodeghiero, F., Goodeve, A.C., Makris, M., Wilde, J.T., Mumford, A.D., Watson, S.P. & Mundell, S.J. (2009) Identification and characterization of a novel P2Y 12 variant in a patient diagnosed with type 1 von Willebrand disease in the European MCMDM-1VWD study. Blood, 113, 4110-4113.
6. Fressinaud, E., Veyradier, A., Truchaud, F., Martin, I., Boyer-Neumann, C., Trossaert, M. & Meyer, D. (1998) Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood, 91, 1325-3131.
7. Goodeve, A., Eikenboom, J., Castaman, G., Rodeghiero, F., Federici, A.B., Batlle, J., Meyer, D., Mazurier, C., Goudemand, J., Schneppenheim, R., Budde, U., Ingerslev, J., Habart, D., Vorlova, Z., Holmberg, L., Lethagen, S., Pasi, J., Hill, F., Hashemi Soteh, M., Baronciani, L., Hallden, C., Guilliatt, A., Lester, W. & Peake, I. (2007) Phenotype and genotype of a cohort of families historically diagnosed with Type 1 von Willebrand Disease in the European study, molecular and clinical markers for the diagnosis and management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood, 109, 112-121.
8. Kleinbaum, D.G., Kupper, L.L. & Muller, K.A. (1987) Applied Regression Analysis and Other Multivariable Methods, 2nd edn. Duxbury Press, Boston.
9. TM. Seminars in Thrombosis and Hemostasis, 21, 106-112.
10. Kunicki, T.J., Federici, A.B., Salomon, D.R., Koziol, J.A., Head, S.R., Mondala, T.S., Chismar, J.D., Baronciani, L., Canciani, M.T. & Peake, I.R. (2004) An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees. Blood, 104, 2359-2367.
11. Nitu-Whalley, I.C., Lee, C.A., Brown, S.A., Riddell, A. & Hermans, C. (2003) The role of the platelet function analyser (PFA-100) in the characterization of patients with von Willebrand's disease and its relationships with von Willebrand factor and the ABO blood group. Haemophilia, 9, 298-302.
12. Podda, G.M., Bucciarelli, P., Lussana, F., Lecchi, A. & Cattaneo, M. (2007) Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time. Journal of Thrombosis and Haemostasis, 5, 2393-2398.
13. Posan, E., McBane, R.D., Grill, D.E., Motsko, C.L. & Nichols, W.L. (2003) Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice. Thrombosis and Haemostasis, 90, 483-490.
14. Quiroga, T., Goycoolea, M., Munoz, B., Morales, M., Aranda, E., Panes, O., Pereira, J. & Mezzano, D. (2004) Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients. Journal of Thrombosis and Haemostasis, 2, 892-898.
15. Rodeghiero, F., Castaman, G., Tosetto, A., Battle, J., Baudo, F., Cappelletti, A., Casana, P., De Bosch, N., Eikenboom, J.C., Federici, A.B., Lethagen, S., Linari, S. & Srivastava, A. (2005) The discriminant power of bleeding history for the diagnosis of von Willebrand disease type 1: an international, multicenter study. Journal of Thrombosis and Haemostasis, 3, 2619-2626.
16. Rodeghiero, F., Castaman, G. & Tosetto, A. (2009) How I treat von Willebrand disease. Blood, 114, 1158-1165.
17. Sadler, J. & Rodeghiero, F. (2005) Provisional criteria for the diagnosis of VWD type 1; on behalf of the SSC Subcommittee on von Willebrand factor. Journal of Thrombosis and Haemostasis, 3, 775-777.
18. Schlammadinger, A., Kerenyi, A., Muszbek, L. & Boda, Z. (2000) Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease. Thrombosis and Haemostasis, 84, 88-92.
19. Tosetto, A., Rodeghiero, F., Castaman, G., Goodeve, A., Federici, A.B., Battle, J., Meyer, D., Fressinaud, E., Mazurier, C., Goudemand, J., Eikenboom, J., Schneppenheim, R., Budde, U., Ingerslev, J., Vorlova, Z., Habart, D., Holmberg, L., Lethagen, S., Pasi, J., Hill, F. & Peake, I. (2006) A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). Journal of Thrombosis and Haemostasis, 4, 766-773.